(R)-3-Hydroxy-1-methyl-pyrrolidine, 98.0%, 10g

tert-butyl (2S,4R)-2-[4-(4-bromophenyl)-1H-imidazol-2-yl]-4-hydroxypyrrolidine-1-carboxylate, 95%, 250mg

2-(2-bromophenyl)-1,3-benzoxazole, 95.0%, 1g

2-{8-[(tert-butoxy)carbonyl]-8-azabicyclo[3.2.1]octan-3-yl}acetic acid, 98%, 250mg

N-benzyl-6-methoxy-1,3-benzothiazol-2-amine, 95.0%, 2.5g

Flacons à vis conique, 1,5 ml, 1000 pièce(s)

5-(3-Bromophenyl)thiazol-2-amine>95.0%(GC)100mg

Boc-Cys(Fm)-OH, 95.0%, 25g

5-Methoxyquinazolin-4(3H)-one, 97.0%, 5g

4-Hydroxy-2,3-dihydroisoindol-1-one, 95.0%, 5g

(2E)-1-(2,4-dimethylphenyl)-3-(4-fluorophenyl)prop-2-en-1-one, 95.0%, 2g

1-Acetyl-1H-indazole-6-boronic acid, pinacol ester, 95.0%, 250mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(1-(tert-butoxycarbonyl)-1H-indol-3-yl)-2-methylpropanoic acid, 95%, 5g